The AARP said it has other concerns about the legislation, such as weakened Medicare and Medicaid and a tax break for drug companies.   " Drug companies and special interests get a sweetheart deal" in the plan, LeaMond said, yet the legislation does nothing to lower the cost of prescription drugs. The Trump administration has said lower drug prices would be a legislative priority.   